Saltigo signs agreement with Daiichi Sankyo

Published: 8-Jul-2013
Manufacturing

Lanxess subsidiary provides contract manufacturing services for Japanese pharmaceutical company


German custom manufacturing specialist Saltigo is continuing the development of its pharmaceutical business portfolio by signing an agreement with Daiichi Sankyo for the provision of contract manufacturing services.

These services are associated with the preparation for commercialisation of one of Daiichi Sankyo’s novel drug pipeline projects.

A signing ceremony took place in Tokyo in the presence of Katsumi Fujimoto, Executive Vice President, Pharmaceutical Technology Division of Daiichi Sankyo, and Wolfgang Schmitz, Managing Director of Saltigo.

Schmitz said: ‘Daiichi Sankyo is one of the largest pharma players in the second-largest pharma market in the world and decided to work with a globally recognised CMO-partner such as our company. So, it is a great honour for Saltigo to enter into this agreement.’

No financial or further details have been revealed.

  • Companies:
  • Saltigo
  • Daiichi Sankyo
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Looking ahead to a challenging year

Read more
Asia is emerging as a rival to the US as a leading source of drug discovery and high end innovation. Both clinical trials activity and investments by drug majors are set to expand in Asia, with India and China leading the charge. But the Indian, Chinese and Philippino governments are proposing to increase price controls on medicines, and lax intellectual property laws across the region could hinder growth.

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
  5. Pharmaceutics International bolsters its prefilled syringe production capabilities The aseptic and oral dosage CDMO has invested USD $3.6m into advanced labelling, fill/finish and automated visual inspection technologies at its Hunt Valley site in Maryland, US

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Looking ahead to a challenging year

Asia is emerging as a rival to the US as a leading source of drug discovery and high end innovation. Both clinical trials activity and investments by drug majors are set to expand in Asia, with India and China leading the charge. But the Indian, Chinese and Philippino governments are proposing to increase price controls on medicines, and lax intellectual property laws across the region could hinder growth.
Manufacturing

Daiichi Sankyo acquires first US-based packaging facility

Strengthens global supply chain capabilities
Manufacturing

Saltigo agrees cooperation with RCA

Extends synthesis services
Manufacturing

Saltigo supports customers in the early phases of active ingredient development

<p>Serving innovative pharmaceutical companies - expertly and flexibly </p><p>Satisfied customers always come back</p>
Media

Saltigo nearly doubles capacity for active ingredient precursor

<p>Saltigo, a wholly owned subsidiary of German speciality chemicals group Lanxess, has nearly doubled capacity for an active ingredient precursor for a major pharmaceutical manufacturer without needing to halt or interrupt the production process. </p>
Manufacturing

Saltigo to showcase portfolio at Chemspec Europe

<p>Saltigo, a global service provider for custom synthesis and custom manufacturing, is set to showcase its product portfolio at Chemspec Europe 2008 next week.</p>
Manufacturing

Saltigo establishes US production and development services for pharmacompanies

<p>LANXESS Corporation has established a new site in Redmond, Washington, to serve the growing pharmaceutical business line of its affiliate, Saltigo GmbH (a subsidiary of LANXESS Deutschland GmbH). </p>
Subscribe now